Merck (MRK) Total Current Liabilities (2016 - 2025)
Historic Total Current Liabilities for Merck (MRK) over the last 17 years, with Q3 2025 value amounting to $28.6 billion.
- Merck's Total Current Liabilities fell 323.8% to $28.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $28.6 billion, marking a year-over-year decrease of 323.8%. This contributed to the annual value of $28.4 billion for FY2024, which is 1060.95% up from last year.
- Per Merck's latest filing, its Total Current Liabilities stood at $28.6 billion for Q3 2025, which was down 323.8% from $26.0 billion recorded in Q2 2025.
- In the past 5 years, Merck's Total Current Liabilities registered a high of $29.6 billion during Q3 2024, and its lowest value of $21.9 billion during Q2 2021.
- For the 5-year period, Merck's Total Current Liabilities averaged around $24.9 billion, with its median value being $24.2 billion (2022).
- In the last 5 years, Merck's Total Current Liabilities tumbled by 1534.46% in 2022 and then surged by 2811.12% in 2024.
- Merck's Total Current Liabilities (Quarter) stood at $23.9 billion in 2021, then grew by 1.54% to $24.2 billion in 2022, then grew by 6.0% to $25.7 billion in 2023, then increased by 10.61% to $28.4 billion in 2024, then grew by 0.73% to $28.6 billion in 2025.
- Its Total Current Liabilities was $28.6 billion in Q3 2025, compared to $26.0 billion in Q2 2025 and $25.2 billion in Q1 2025.